Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Bioanalytical Systems, Inc. | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Bioanalytical Systems, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASi

1Q Revenues: $10.9 million (+11%)

1Q Earnings: $556,000 (loss of $716,000 1Q2006)

Comments: Bioanalytical and toxicology operations revenues increased in the quarter, revenues from product sales were flat, and revenues from clinical operations declined as a result of the loss of a significant client FY2006. The company had reduced selling, R&D, and general and administrative expenses to $2.7 million, compared to $4.1 million in 1Q2006. These expenses were favorably impacted by reductions in headcount announced in September 2006 and reduction of amortization expense as a result of an impairment charge recorded in the third quarter of fiscal 2006.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics